Peptide record

TPDB07791

Antibacterial Anticancer Antidiabetic Antifungal Antiparasitic Antiviral Toxicity standard
15 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07791
Antibacterial Anticancer Antidiabetic Antifungal Antiparasitic Antiviral Toxicity
Anti-infective peptides Cardiometabolic peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb ToxinPred 3.0
standard
No
A 15-aa standard-residue multi-activity (Antibacterial, Anticancer, Antidiabetic, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FIFPKKNIINSLFGR
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C87H136N22O19
ADCEQHMTWYV
IF
1794.17
11.64
3
0
7
+3
0.88
0.240
104.00
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
3
Residue Composition
number
0
A
1
R
2
N
0
D
0
C
0
E
0
Q
1
G
0
H
3
I
1
L
2
K
0
M
3
F
1
P
1
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 1 N: 2 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 3 L: 1 K: 2 M: 0 F: 3 P: 1 S: 1 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
15 reviewed residue count
C87H136N22O19 sequence-only estimate (linear, free termini)
1794.17 sequence-only estimate (linear, free termini)
11.64 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
0.88 sequence-only estimate (linear, free termini)
0.240 sequence-only estimate (linear, free termini)
Evidence Records 13 records
Evidence 1 Activity

Activity

MIC
Antibacterial
>126 µg/mL

Target

E.coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram- bacteria E.coli (MIC >126 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 16 ug/ml), Gram+ bacteria S. aureus (MIC 1
Evidence 2 Activity

Activity

MIC
Antibacterial
16 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

(MIC >126 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 16 ug/ml), Gram+ bacteria S. aureus (MIC 16 ug/ml), and yeast C. albicans (MIC 16 ug/ml). Updated 7/2021
Evidence 3 Activity

Activity

MIC
Antibacterial
16 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

called P. aeruginosa) (MIC 16 ug/ml), Gram+ bacteria S. aureus (MIC 16 ug/ml), and yeast C. albicans (MIC 16 ug/ml). Updated 7/2021
Evidence 4 Activity

Activity

MIC
Antifungal
>126 µg/mL

Target

E.coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram- bacteria E.coli (MIC >126 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 16 ug/ml), Gram+ bacteria S. aureus (MIC 1
Evidence 5 Activity

Activity

MIC
Antifungal
16 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

(MIC >126 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 16 ug/ml), Gram+ bacteria S. aureus (MIC 16 ug/ml), and yeast C. albicans (MIC 16 ug/ml). Updated 7/2021
Evidence 6 Activity

Activity

MIC
Antifungal
16 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

called P. aeruginosa) (MIC 16 ug/ml), Gram+ bacteria S. aureus (MIC 16 ug/ml), and yeast C. albicans (MIC 16 ug/ml). Updated 7/2021
Evidence 7 Activity

Activity

MIC
Antiparasitic
>126 µg/mL

Target

E.coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Gram- bacteria E.coli (MIC >126 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 16 ug/ml), Gram+ bacteria S. aureus (MIC 1
Evidence 8 Activity

Activity

MIC
Antiparasitic
16 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

(MIC >126 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 16 ug/ml), Gram+ bacteria S. aureus (MIC 16 ug/ml), and yeast C. albicans (MIC 16 ug/ml). Updated 7/2021
Evidence 9 Activity

Activity

MIC
Antiparasitic
16 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

called P. aeruginosa) (MIC 16 ug/ml), Gram+ bacteria S. aureus (MIC 16 ug/ml), and yeast C. albicans (MIC 16 ug/ml). Updated 7/2021
Evidence 10 Activity

Activity

MIC
Antiviral
>126 µg/mL

Target

E.coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against Gram- bacteria E.coli (MIC >126 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 16 ug/ml), Gram+ bacteria S. aureus (MIC 1
Evidence 11 Activity

Activity

MIC
Antiviral
16 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

(MIC >126 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 16 ug/ml), Gram+ bacteria S. aureus (MIC 16 ug/ml), and yeast C. albicans (MIC 16 ug/ml). Updated 7/2021
Evidence 12 Activity

Activity

MIC
Antiviral
16 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

called P. aeruginosa) (MIC 16 ug/ml), Gram+ bacteria S. aureus (MIC 16 ug/ml), and yeast C. albicans (MIC 16 ug/ml). Updated 7/2021
Evidence 13 Activity

Activity

Toxicity
Hemolytic Cytotoxic
- | NA | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs. | J Proteome Res | 2012